
Corporate ActionJun 15, 2026, 12:01 PM
Regentis Biomaterials Withdraws F-1 Registration for Public Offering
AI Summary
Regentis Biomaterials Ltd. announced the withdrawal of its Form F-1 Registration Statement (File No. 333-295510), effective June 15, 2026. The company has decided not to proceed with the public offering to which the Registration Statement relates.
Key Highlights
- Regentis Biomaterials Ltd. withdrew its Form F-1 Registration Statement.
- The withdrawal was effective as of June 15, 2026.
- The company decided not to pursue the public offering related to the Registration Statement.
Price Impact
More from RGNT
Corporate GovernanceJun 9, 9:31 AM
Regentis Biomaterials Ltd. Details Director Indemnification and Unregistered Securities Sales
Business UpdateJun 8, 9:02 AM
Regentis to Begin European Surgeon Training for GelrinC in Q3 2026
AGM/EGMJun 4, 4:37 PM
Regentis Biomaterials Ltd. Announces Annual General Meeting on July 2, 2026